scholarly journals Metastatic Clear Cell Renal Cell Carcinoma with an Unknown Primary in a Living Donor Kidney Transplant Recipient

2018 ◽  
Vol 4 (5) ◽  
Author(s):  
Ahmed Elfadaly ◽  
Nelish Ardeshna ◽  
Obinna Ekwenna ◽  
Jorge Ortiz
Keyword(s):  
Renal Cell Carcinoma ◽  
Transplant Recipient ◽  
Living Donor ◽  
Clear Cell ◽  
Kidney Transplant Recipient ◽  
Unknown Primary ◽  
Donor Kidney ◽  
Cell Renal Cell Carcinoma ◽  
Living Donor Kidney Transplant ◽  
Living Donor Kidney

scholarly journals Primary omental pleomorphic liposarcoma identified at autopsy in a living donor kidney transplant recipient

2012 ◽  
Vol 1 (1) ◽  
pp. 39-42 ◽  
Author(s):  
Yusuke Tomita ◽  
Kotaro Kai ◽  
Hiroyuki Shirai ◽  
Ichiro Nakajima ◽  
Saeko Yoshizawa ◽  
...  
Keyword(s):  
Transplant Recipient ◽  
Kidney Transplant ◽  
Living Donor ◽  
Kidney Transplant Recipient ◽  
Donor Kidney ◽  
Pleomorphic Liposarcoma ◽  
Living Donor Kidney Transplant ◽  
Living Donor Kidney

scholarly journals Endovascular Treatment of Renal Artery Thrombosis in Living-Donor Kidney Transplant Recipient With Severe COVID-19 Disease

2022 ◽  
pp. 152660282110687
Author(s):  
Carlos Veterano ◽  
Inês Antunes ◽  
Andreia Coelho ◽  
Ivone Silva ◽  
Rui Almeida ◽  
...  
Keyword(s):  
Transplant Recipient ◽  
Renal Artery ◽  
Kidney Transplant ◽  
Living Donor ◽  
Kidney Transplant Recipient ◽  
Donor Kidney ◽  
Thrombotic Risk ◽  
Renal Artery Thrombosis ◽  
Artery Thrombosis ◽  
Living Donor Kidney Transplant

Purpose: Coronavirus disease 2019 (COVID-19) patients have a higher prevalence of micro-and macrovascular thrombotic events. However, the underlying mechanism for the increased thrombotic risk is not completely understood. Solid organ transplant recipients infected with SARS-CoV-2 may have an exponential increase in thrombotic risk and the best management strategy is unknown. Case Report: A female kidney transplant recipient presented with allograft’s renal artery thrombosis after a recent COVID-19 infection. Due to the risk of kidney failure or exclusion, catheter directed thrombolysis was performed. Residual thrombus was excluded using an endoprosthesis with an excellent result. There were no adverse events and kidney function improved. Conclusion: This paper reports the endovascular treatment of renal artery thrombosis in a living-donor kidney transplant recipient with severe COVID-19 disease.

Sign in / Sign up

Export Citation Format

Share Document